PF-4776548
CAS No. 1515856-61-7
PF-4776548 ( PF-04776548 )
Catalog No. M12117 CAS No. 1515856-61-7
PF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-4776548
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
DescriptionPF-4776548 (PF-04776548) novel HIV integrase inhibitor for treatment of HIV infections.
-
SynonymsPF-04776548
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1515856-61-7
-
Formula Weight341.34
-
Molecular FormulaC18H16FN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(3-(4-fluoro-2-methoxy-benzyl)-7-hydroxy-8,9-dihydro-3H,7H-pyrrolo[2,3-c][1,7]naphthyridin-6-one)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harrison A, et al. Xenobiotica. 2012 Jan;42(1):57-74.
molnova catalog
related products
-
Abacavir
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
-
BMS-707035
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.
-
Dolutegravir sodium
Dolutegravir sodium (GSK-1349572A) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM.